Skip to main content
Medical information Clinical review pending

Cardiology

Hdl Cholesterol Subclasses Test

The HDL Cholesterol Subclasses Test measures HDL-2 and HDL-3 levels to assess heart disease risk. Understanding these levels helps in early detection and management of cardiovascular health.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (2 mL minimum) serum collected in an SST tube.
Results
Sample by 7th of the month; Report after 2-3 weeks. Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. A duly filled Test Send Out Consent Form (Form 35) is mandatory.
Test priceKSh 20,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Hdl Cholesterol Subclasses Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a family history of premature heart disease.
  • ✓Patients with existing cardiovascular conditions.
  • ✓People with risk factors like diabetes, high blood pressure, or obesity.
  • ✓Patients undergoing cholesterol management therapy.
  • ✓Individuals seeking a more detailed cardiovascular risk assessment.
02

In plain language

What this test helps you understand

This test provides a more detailed assessment of HDL cholesterol levels than a standard lipid panel. It helps identify specific imbalances in HDL subclasses that may indicate an increased risk for cardiovascular disease, even when overall HDL levels appear normal. This information can aid in risk stratification and personalized treatment planning.
The HDL Cholesterol Subclasses Test is a diagnostic tool used to evaluate the levels of high-density lipoprotein (HDL) cholesterol in your blood. This test specifically measures two main subclasses of HDL: HDL-2 and HDL-3. HDL cholesterol is often referred to as 'good' cholesterol because it helps remove other forms of cholesterol from your bloodstream, transporting it back to the liver for processing or removal. Understanding the balance between HDL-2 and HDL-3 can provide valuable insights into your cardiovascular health. HDL-2 particles are generally considered more protective against heart disease than HDL-3 particles. This test helps healthcare providers assess your individual risk profile and guide appropriate management strategies.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. A duly filled Test Send Out Consent Form (Form 35) is mandatory.
Sample4 mL (2 mL minimum) serum collected in an SST tube.
MethodologyPrecipitation, Colorimetric, Enzymatic methods are used.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test measures specific HDL subclasses but does not provide a complete picture of cardiovascular risk. Results should be interpreted in conjunction with other clinical information, risk factors, and potentially other laboratory tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

HDL stands for High-Density Lipoprotein, often called 'good' cholesterol. It helps remove excess cholesterol from your arteries and transport it back to the liver.
These are two main subclasses of HDL cholesterol. HDL-2 particles are generally considered more effective at protecting against heart disease than HDL-3 particles.
This test provides a more detailed look at your HDL levels than a standard lipid panel, helping to better assess your risk for heart disease.
Confirm with the laboratory before booking regarding fasting requirements.
Your doctor will interpret the results based on your individual health profile and risk factors. Higher HDL-2 levels are generally favourable.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp